DEBORAH HOOD: Open Payments
NPI 1922565738 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 24 payments from 7 companies in 2025. Trend: 2023 $1,388 · 2024 $707 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $153 |
| Otsuka America Pharmaceutical, Inc. | 4 | $115 |
| Dexcom, Inc. | 3 | $62 |
| Lundbeck LLC | 2 | $55 |
| Amgen Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: REXULTI, QULIPTA, Dexcom G6 Transmitter, VRAYLAR, EVENITY, OFEV, MOUNJARO, UBRELVY.
Industry payments across MS — which companies pay providers there.
